US EditionUnited Kingdom Alert for Death Risk Using Mounjaro and Similar – Young Pan
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
The United Kingdom Medicines and Health Products Regulatory Agency (MHRA) issued a communication alerting patients and health professionals about the use of medicinal products of the GLP-1 class, which includes names known as Mounjaro (tirjepated), used for the treatment of diabetes and weight loss. The body highlighted concern with acute pancreatitis cases, including reports of deaths related to this condition. It also includes exenatized, lira…
Health authorities in the United Kingdom issued a warning about the risk of pancreatitis due to the use of medicines such as Mounjaro and Wegovy. The warning was directed to doctors and patients after the registration of serious cases of disease, some of them with fatal outcome. The two medicines belong to a class used in treatment of type 2 diabetes and, more recently, in weight control. With the expansion of use, the British system of pharmaco…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
